News and Events
2006
Teikoku Enters into an Agreement with Altea Therapeutics for the Development, Manufacture, and Commercialization in Japan of a New Transdermal Therapy for Parkinson’s Disease
February 1, 2006
In furthering it's strength in transdermal drug delivery, Teikoku signs an agreement with Altea Therapeutics to develop and commercialize a new patch therapy for managing Parkinson's Disease, utilizing Altea Therapeutics' PassPort technology.
READ MORE2005
Study Compares Lidoderm Patch and Celebrex for Osteoarthritis Pain
March 31, 2005
Endo Pharmaceuticals has released clinical trial data that found patients receiving either Lidoderm or Celebrex 200 mg for pain...
READ MORE2004
Teikoku Pharma Expands Manufacturing Capabilities to the United States
December 2, 2004
Teikoku today announced its relocation to San Jose, California.
READ MORE